These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36882189)

  • 1. Astragaloside IV attenuates myocardial dysfunction in diabetic cardiomyopathy rats through downregulation of CD36-mediated ferroptosis.
    Li X; Li Z; Dong X; Wu Y; Li B; Kuang B; Chen G; Zhang L
    Phytother Res; 2023 Jul; 37(7):3042-3056. PubMed ID: 36882189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of AS-IV on diabetic cardiomyopathy by improving myocardial lipid metabolism in rat models of T2DM.
    Wang Z; Zhu Y; Zhang Y; Zhang J; Ji T; Li W; Li W
    Biomed Pharmacother; 2020 Jul; 127():110081. PubMed ID: 32244194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rev-erbα attenuates diabetic myocardial injury through regulation of ferroptosis.
    Tian H; Huang Q; Cheng J; Xiong Y; Xia Z
    Cell Signal; 2024 Feb; 114():111006. PubMed ID: 38086436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy.
    Du S; Shi H; Xiong L; Wang P; Shi Y
    Front Endocrinol (Lausanne); 2022; 13():1011669. PubMed ID: 36313744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray profiling analysis identifies the mechanism of miR-200b-3p/mRNA-CD36 affecting diabetic cardiomyopathy via peroxisome proliferator activated receptor-γ signaling pathway.
    Xu L; Chen W; Ma M; Chen A; Tang C; Zhang C; Cai L
    J Cell Biochem; 2019 Apr; 120(4):5193-5206. PubMed ID: 30506990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canagliflozin Attenuates Lipotoxicity in Cardiomyocytes by Inhibiting Inflammation and Ferroptosis through Activating AMPK Pathway.
    Zhang W; Lu J; Wang Y; Sun P; Gao T; Xu N; Zhang Y; Xie W
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of the (pro)renin receptor alleviates ferroptosis-associated cardiac pathological changes via the NCOA 4-mediated ferritinophagy pathway in diabetic cardiomyopathy.
    Zhang X; Dong X; Jie H; Li S; Li H; Su Y; Li L; Kang L; Dong B; Zhang Y
    Int Immunopharmacol; 2024 Sep; 138():112605. PubMed ID: 38963979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroptosis: roles and molecular mechanisms in diabetic cardiomyopathy.
    Zhao Y; Pan B; Lv X; Chen C; Li K; Wang Y; Liu J
    Front Endocrinol (Lausanne); 2023; 14():1140644. PubMed ID: 37152931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paeoniflorin confers ferroptosis resistance by regulating the gut microbiota and its metabolites in diabetic cardiomyopathy.
    Wu H; Zhang P; Zhou J; Hu S; Hao J; Zhong Z; Yu H; Yang J; Chi J; Guo H
    Am J Physiol Cell Physiol; 2024 Mar; 326(3):C724-C741. PubMed ID: 38223927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis: A New Mechanism in Diabetic Cardiomyopathy.
    Song Z; Wang J; Zhang L
    Int J Med Sci; 2024; 21(4):612-622. PubMed ID: 38464828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irisin attenuates type 1 diabetic cardiomyopathy by anti-ferroptosis via SIRT1-mediated deacetylation of p53.
    Tang YJ; Zhang Z; Yan T; Chen K; Xu GF; Xiong SQ; Wu DQ; Chen J; Jose PA; Zeng CY; Fu JJ
    Cardiovasc Diabetol; 2024 Apr; 23(1):116. PubMed ID: 38566123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of sarcolemmal FAT/CD36 by sulfo-N-succinimidyl oleate rapidly corrects metabolism and restores function in the diabetic heart following hypoxia/reoxygenation.
    Mansor LS; Sousa Fialho MDL; Yea G; Coumans WA; West JA; Kerr M; Carr CA; Luiken JJFP; Glatz JFC; Evans RD; Griffin JL; Tyler DJ; Clarke K; Heather LC
    Cardiovasc Res; 2017 Jun; 113(7):737-748. PubMed ID: 28419197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medium & long-chain acylcarnitine's relation to lipid metabolism as potential predictors for diabetic cardiomyopathy: a metabolomic study.
    Zheng DM; An ZN; Ge MH; Wei DZ; Jiang DW; Xing XJ; Shen XL; Liu C
    Lipids Health Dis; 2021 Nov; 20(1):151. PubMed ID: 34727932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insight for SS‑31 in treating diabetic cardiomyopathy: Activation of mitoGPX4 and alleviation of mitochondria‑dependent ferroptosis.
    Xiong L; Hu H; Zhu F; Shi H; Fan X; Pan S; Zhu F; Zhang J; Yu Z; Shi Y
    Int J Mol Med; 2024 Dec; 54(6):. PubMed ID: 39364755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragalus polysaccharides alleviates cardiac hypertrophy in diabetic cardiomyopathy via inhibiting the BMP10-mediated signaling pathway.
    Sun S; Yang S; Zhang N; Yu C; Liu J; Feng W; Xu W; Mao Y
    Phytomedicine; 2023 Jan; 109():154543. PubMed ID: 36610158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative stress.
    Lin C; Guo Y; Xia Y; Li C; Xu X; Qi T; Zhang F; Fan M; Hu G; Zhao H; Zhao H; Liu R; Gao E; Yan W; Tao L
    J Mol Cell Cardiol; 2021 Nov; 160():27-41. PubMed ID: 34224725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic overexpression of miR-92a-2-5p ameliorated cardiomyocyte oxidative stress injury in the development of diabetic cardiomyopathy.
    Yu M; Sun Y; Shan X; Yang F; Chu G; Chen Q; Han L; Guo Z; Wang G
    Cell Mol Biol Lett; 2022 Oct; 27(1):85. PubMed ID: 36209049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apocynin attenuates diabetic cardiomyopathy by suppressing ASK1-p38/JNK signaling.
    Ding W; Feng H; Li WJ; Liao HH; Zhang N; Zhou ZY; Mou SQ; Lin Z; Xia-He NZ; Xia H; Tang QZ
    Eur J Pharmacol; 2021 Oct; 909():174402. PubMed ID: 34348125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxiredomin-4 ameliorates lipotoxicity-induced oxidative stress and apoptosis in diabetic cardiomyopathy.
    Zhang B; Li X; Liu G; Zhang C; Zhang X; Shen Q; Sun G; Sun X
    Biomed Pharmacother; 2021 Sep; 141():111780. PubMed ID: 34130124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-Gingerol Alleviates Ferroptosis and Inflammation of Diabetic Cardiomyopathy via the Nrf2/HO-1 Pathway.
    Wu S; Zhu J; Wu G; Hu Z; Ying P; Bao Z; Ding Z; Tan X
    Oxid Med Cell Longev; 2022; 2022():3027514. PubMed ID: 36624878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.